Skip to content

CHAMP App Cardiac Study and Repository

CHAMP App Cardiac Study: Evaluation of Software Functions for Asynchronous Monitoring of Children With Complex Congenital Heart Disease in the Home Setting and Data Repository

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06034392
Acronym
CHAMP
Enrollment
1000
Registered
2023-09-13
Start date
2023-08-25
Completion date
2026-12-31
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Defects, Congenital, Pediatrics

Keywords

mHealth, Software Platform

Brief summary

This is a multi-site research study with an optional research repository that will consist of clinically derived data and photographic or video images of patients in the home setting with complex health conditions to evaluate the safety and efficacy of the CHAMP® software platform, with data and photographic or video images input and/or uploaded by the parent or other legally authorized representative (LAR) of patients with complex congenital heart disease as a target population.

Detailed description

Study objectives 1. To evaluate whether data collection and transmission through the CHAMP software platform improves communication between health care providers and parents/LAR that positively affects the care of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated 2. To determine the accuracy of data obtained regarding observation by parent or caregiver of the condition of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated. 3. To evaluate the use of the CHAMP App for clinical purposes, including user satisfaction with the data entry, parental self-management, and transmission capabilities. 4. To evaluate the real-world performance analytics (RWPA) of the CHAMP software platform for transfer of parent-entered data for children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated. Endpoints 1. To demonstrate that parents and caregivers for children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated can accurately identify and transmit to healthcare providers specific health-related data including intake of food, fluids and mediations; output, including urination, defecation, and vomiting; weight; vital signs including oxygen saturation as measured by pulse oximetry; heart rate as measured either by a heart rate monitor or manually by the parent or caregiver; and temperature, measured by a reliable thermometer; and the value and reliability of videos provided by parents and caregivers regarding behavior of pediatric study participants for use in evaluating participant's health status. 2. To demonstrate that data obtained through the use of devices such as pulse oximeters, as entered into the app by parents and caregivers, provide valuable information regarding the health status of children with Complex Diagnoses in a home setting. 3. To demonstrate characteristics of CHAMP through real world health analytics (RWHA), user experience analytics (UX), and product performance analytics (PPA). The study duration is open-ended for safety, effectiveness, and performance of the CHAMP app. Unless consent is withdrawn, data will be kept and used for data analysis and, if consented to the research repository for multi-site research purposes indefinitely. At age 18, previously pediatric patients may be approached for reconsent.

Interventions

DEVICECHAMP App

CHAMP® App is a downloadable software mobile Application with a Software Platform. CHAMP® App is an electronic version of data entry for children with conditions that require close monitoring from their homes. The primary Intended Use is to relay monitoring information from homes to the health care team. This monitoring includes data options that can facilitate the collection of monitoring data of children in the home setting to improve communications between parents at home and remote caregivers. The CHAMP® App itself does not do home monitoring of the child's medical condition. It is not designed to alert parents if data entered has reached a red flag (problem) level. Users of the CHAMP App are advised in writing and in the informed consent process that urgent medical conditions should not be managed through the CHAMP App, and that appropriate emergency care should be obtained directly rather than through the CHAMP App.

Sponsors

Lori Erickson
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age 0-17 years with a parent/Legally authorized representative * Diagnosed with a complex health condition in which asynchronous monitoring in the home setting is appropriate. * Pediatric patient's cardiac care team has decided that the patient's treatment plan may benefit from remote home monitoring. * Institution that the subject is followed through clinically has been an approved as site for the CHAMP app study with Children's Mercy Kansas City. Adult participants * Parents/Legally authorized representatives of pediatric subject. * Healthcare team users at an institution that is an approved site for the CHAMP app Study with Children's Mercy Kansas City.

Exclusion criteria

* Inability to be discharged to care in the home setting. * Those not meeting the above inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Human factors/usability engineering: Login failuresOver a 3 month periodRate of attempts of log-in failures
Human factors/usability engineering: ImprecisionOver a 3 month periodRate of data values reported with imprecision
Clinical Safety: Anticipated adverse eventsOver a 3 month periodAnticipated Adverse event rates
Clinical Safety: Event resolution- anticipatedTime in days, reported over the last 3 monthsTime to resolve anticipated adverse events
Clinical Safety: Unanticipated Adverse eventsTime in days, reported over the last 3 monthsUnanticipated adverse event rates
Clinical Safety: Event resolution- unanticipatedTime in days, reported over the last 3 monthsTime to resolve unanticipated adverse events
Health Benefits: AdherenceMeasurement of adherence to daily data entry per each patient/parent over 3 month period on non-hospitalized days, during the study periodRate of adherence to daily data entry
User Satisfaction: ComplaintsOver a 3 month periodComplaint rates via the healthcare team web portal
User Satisfaction CHAMP Videothrough study completion, an average of 9 monthsFeedback from healthcare team will be received via treatment endpoint survey questions. Likert scale questions 1-strongly disagree to 5 strongly agree (Using CHAMP videos for the interstage monitoring of this patient improved clinical decisions for the home monitoring team). Available to put in comments.
User Satisfaction: Communicationthrough study completion, an average of 9 monthsFeedback from healthcare team will be received via treatment endpoint survey questions Likert scale questions 1-strongly disagree to 5 strongly agree ( Using CHAMP for the interstage monitoring of this patient improved communication with the parents at home.) Available to put in comments.
User EngagementOver a 3 month perriodTotal number of registered users (Active, treatment endpoint reached) and data totals per parent entered measure. De-identified Demographics and age areas utilization -Utilization across the number of pediatric sites, healthcare teams
CHAMP app performance: DowntimeOver a 3 month periodProduct Performance Analytics measured through Any system downtime
CHAMP app performance: CybersecurityOver a 3 month periodProduct Performance Analytics measured through Any reported breaches
CHAMP app performanceQuarterly review of CHAMP App Performance will be measure over the preceding 3 months for frequency of changes requiredProduct Performance Analytics measured through --Bug/defect rate or Version failure rates

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLori Erickson, PhD

Director, Remote Health Solutions Children's Mercy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026